 | • レポートコード：QAF27867 • 出版社/出版日：QYResearch / 2021年4月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、137ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界の狂犬病ワクチン市場について種類別（ベロ細胞狂犬病ワクチン、BHK、ひよこ胚細胞狂犬病ワクチン、その他）、用途別（暴露前予防、暴露後予防）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・狂犬病ワクチン市場の概要 ・世界の主要地域別狂犬病ワクチン市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界の狂犬病ワクチン市場規模2016-2021：種類別（ベロ細胞狂犬病ワクチン、BHK、ひよこ胚細胞狂犬病ワクチン、その他） ・世界の狂犬病ワクチン市場予測2012-2027：種類別（ベロ細胞狂犬病ワクチン、BHK、ひよこ胚細胞狂犬病ワクチン、その他） ・世界の狂犬病ワクチン市場規模2016-2021：用途別（暴露前予防、暴露後予防） ・世界の狂犬病ワクチン市場予測2012-2027：用途別（暴露前予防、暴露後予防） ・狂犬病ワクチンのアメリカ市場規模と予測2016-2021 ・狂犬病ワクチンのヨーロッパ市場規模と予測2016-2021 ・狂犬病ワクチンの中国市場規模と予測2016-2021 ・狂犬病ワクチンの日本市場規模と予測2016-2021 ・狂犬病ワクチンの東南アジア市場規模と予測2016-2021 ・狂犬病ワクチンのインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （GSK (Novartis)、Sanofi-Pasteur、Chengda、Yisheng、Prcmise、VACN、Changsheng、BCHT、Hissen） ・狂犬病ワクチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・狂犬病ワクチンの市場動向・機会・課題 ・調査の結論 |
Rabies vaccine is an active immunizing agent used to prevent infection caused by the rabies virus. The vaccine works by causing your body to produce its own protection (antibodies) against the rabies virus.
Every year more than 5.5 million people have died for rabies, mostly in Asia and Africa. With the implementation of China’s two-child policy, downstream demand for rabies vaccine will not decrease in the coming few years.
Rabies vaccine is an irreplaceable product, so profile of rabies vaccine is very large. But due to its security requirements than the general drugs, the entire vaccine industry from R & D, production to distribution, sales and after-sales feedback link subject to very strict regulation. So, production companies are not as much as we imagined.
Market Analysis and Insights: Global Rabies Vaccine Market
The global Rabies Vaccine market was valued at US$ 908 in 2020 and will reach US$ 1148.9 million by the end of 2027, growing at a CAGR of 4.0% during 2022-2027.
Global Rabies Vaccine Scope and Market Size
The global Rabies Vaccine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Rabies Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Vero Cell Rabies Vaccine
BHK
Chick Embryo Cell Rabies Vaccine
Others
Segment by Application
Pre-exposure Prophylaxis
Post-exposure Prophylaxis
The Rabies Vaccine market is analysed and market size information is provided by regions (countries). Segment by Application, the Rabies Vaccine market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
GSK (Novartis)
Sanofi-Pasteur
Chengda
Yisheng
Prcmise
VACN
Changsheng
BCHT
Hissen
1 Rabies Vaccine Market Overview
1.1 Rabies Vaccine Product Scope
1.2 Rabies Vaccine Segment by Type
1.2.1 Global Rabies Vaccine Sales by Type (2016 & 2021 & 2027)
1.2.2 Vero Cell Rabies Vaccine
1.2.3 BHK
1.2.4 Chick Embryo Cell Rabies Vaccine
1.2.5 Others
1.3 Rabies Vaccine Segment by Application
1.3.1 Global Rabies Vaccine Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Pre-exposure Prophylaxis
1.3.3 Post-exposure Prophylaxis
1.4 Rabies Vaccine Market Estimates and Forecasts (2016-2027)
1.4.1 Global Rabies Vaccine Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Rabies Vaccine Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Rabies Vaccine Price Trends (2016-2027)
2 Rabies Vaccine Estimates and Forecasts by Region
2.1 Global Rabies Vaccine Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Rabies Vaccine Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Rabies Vaccine Sales Market Share by Region (2016-2021)
2.2.2 Global Rabies Vaccine Revenue Market Share by Region (2016-2021)
2.3 Global Rabies Vaccine Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Rabies Vaccine Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Rabies Vaccine Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Rabies Vaccine Estimates and Projections (2016-2027)
2.4.2 Europe Rabies Vaccine Estimates and Projections (2016-2027)
2.4.3 China Rabies Vaccine Estimates and Projections (2016-2027)
2.4.4 Japan Rabies Vaccine Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Rabies Vaccine Estimates and Projections (2016-2027)
2.4.6 India Rabies Vaccine Estimates and Projections (2016-2027)
3 Global Rabies Vaccine Competition Landscape by Players
3.1 Global Top Rabies Vaccine Players by Sales (2016-2021)
3.2 Global Top Rabies Vaccine Players by Revenue (2016-2021)
3.3 Global Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Rabies Vaccine as of 2020)
3.4 Global Rabies Vaccine Average Price by Company (2016-2021)
3.5 Manufacturers Rabies Vaccine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Rabies Vaccine Market Size by Type
4.1 Global Rabies Vaccine Historic Market Review by Type (2016-2021)
4.1.1 Global Rabies Vaccine Sales Market Share by Type (2016-2021)
4.1.2 Global Rabies Vaccine Revenue Market Share by Type (2016-2021)
4.1.3 Global Rabies Vaccine Price by Type (2016-2021)
4.2 Global Rabies Vaccine Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Rabies Vaccine Sales Forecast by Type (2022-2027)
4.2.2 Global Rabies Vaccine Revenue Forecast by Type (2022-2027)
4.2.3 Global Rabies Vaccine Price Forecast by Type (2022-2027)
5 Global Rabies Vaccine Market Size by Application
5.1 Global Rabies Vaccine Historic Market Review by Application (2016-2021)
5.1.1 Global Rabies Vaccine Sales Market Share by Application (2016-2021)
5.1.2 Global Rabies Vaccine Revenue Market Share by Application (2016-2021)
5.1.3 Global Rabies Vaccine Price by Application (2016-2021)
5.2 Global Rabies Vaccine Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Rabies Vaccine Sales Forecast by Application (2022-2027)
5.2.2 Global Rabies Vaccine Revenue Forecast by Application (2022-2027)
5.2.3 Global Rabies Vaccine Price Forecast by Application (2022-2027)
6 North America Rabies Vaccine Market Facts & Figures
6.1 North America Rabies Vaccine Sales by Company
6.1.1 North America Rabies Vaccine Sales by Company (2016-2021)
6.1.2 North America Rabies Vaccine Revenue by Company (2016-2021)
6.2 North America Rabies Vaccine Sales Breakdown by Type
6.2.1 North America Rabies Vaccine Sales Breakdown by Type (2016-2021)
6.2.2 North America Rabies Vaccine Sales Breakdown by Type (2022-2027)
6.3 North America Rabies Vaccine Sales Breakdown by Application
6.3.1 North America Rabies Vaccine Sales Breakdown by Application (2016-2021)
6.3.2 North America Rabies Vaccine Sales Breakdown by Application (2022-2027)
7 Europe Rabies Vaccine Market Facts & Figures
7.1 Europe Rabies Vaccine Sales by Company
7.1.1 Europe Rabies Vaccine Sales by Company (2016-2021)
7.1.2 Europe Rabies Vaccine Revenue by Company (2016-2021)
7.2 Europe Rabies Vaccine Sales Breakdown by Type
7.2.1 Europe Rabies Vaccine Sales Breakdown by Type (2016-2021)
7.2.2 Europe Rabies Vaccine Sales Breakdown by Type (2022-2027)
7.3 Europe Rabies Vaccine Sales Breakdown by Application
7.3.1 Europe 137 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 137 Sales Breakdown by Application (2022-2027)
8 China Rabies Vaccine Market Facts & Figures
8.1 China Rabies Vaccine Sales by Company
8.1.1 China Rabies Vaccine Sales by Company (2016-2021)
8.1.2 China Rabies Vaccine Revenue by Company (2016-2021)
8.2 China Rabies Vaccine Sales Breakdown by Type
8.2.1 China Rabies Vaccine Sales Breakdown by Type (2016-2021)
8.2.2 China Rabies Vaccine Sales Breakdown by Type (2022-2027)
8.3 China Rabies Vaccine Sales Breakdown by Application
8.3.1 China 247 Sales Breakdown by Application (2016-2021)
8.3.2 China 247 Sales Breakdown by Application (2022-2027)
9 Japan Rabies Vaccine Market Facts & Figures
9.1 Japan Rabies Vaccine Sales by Company
9.1.1 Japan Rabies Vaccine Sales by Company (2016-2021)
9.1.2 Japan Rabies Vaccine Revenue by Company (2016-2021)
9.2 Japan Rabies Vaccine Sales Breakdown by Type
9.2.1 Japan Rabies Vaccine Sales Breakdown by Type (2016-2021)
9.2.2 Japan Rabies Vaccine Sales Breakdown by Type (2022-2027)
9.3 Japan Rabies Vaccine Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Rabies Vaccine Market Facts & Figures
10.1 Southeast Asia Rabies Vaccine Sales by Company
10.1.1 Southeast Asia Rabies Vaccine Sales by Company (2016-2021)
10.1.2 Southeast Asia Rabies Vaccine Revenue by Company (2016-2021)
10.2 Southeast Asia Rabies Vaccine Sales Breakdown by Type
10.2.1 Southeast Asia Rabies Vaccine Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Rabies Vaccine Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Rabies Vaccine Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Rabies Vaccine Market Facts & Figures
11.1 India Rabies Vaccine Sales by Company
11.1.1 India Rabies Vaccine Sales by Company (2016-2021)
11.1.2 India Rabies Vaccine Revenue by Company (2016-2021)
11.2 India Rabies Vaccine Sales Breakdown by Type
11.2.1 India Rabies Vaccine Sales Breakdown by Type (2016-2021)
11.2.2 India Rabies Vaccine Sales Breakdown by Type (2022-2027)
11.3 India Rabies Vaccine Sales Breakdown by Application
11.3.1 India Rabies Vaccine Sales Breakdown by Application (2016-2021)
11.3.2 India Rabies Vaccine Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Rabies Vaccine Business
12.1 GSK (Novartis)
12.1.1 GSK (Novartis) Corporation Information
12.1.2 GSK (Novartis) Business Overview
12.1.3 GSK (Novartis) Rabies Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 GSK (Novartis) Rabies Vaccine Products Offered
12.1.5 GSK (Novartis) Recent Development
12.2 Sanofi-Pasteur
12.2.1 Sanofi-Pasteur Corporation Information
12.2.2 Sanofi-Pasteur Business Overview
12.2.3 Sanofi-Pasteur Rabies Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Sanofi-Pasteur Rabies Vaccine Products Offered
12.2.5 Sanofi-Pasteur Recent Development
12.3 Chengda
12.3.1 Chengda Corporation Information
12.3.2 Chengda Business Overview
12.3.3 Chengda Rabies Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Chengda Rabies Vaccine Products Offered
12.3.5 Chengda Recent Development
12.4 Yisheng
12.4.1 Yisheng Corporation Information
12.4.2 Yisheng Business Overview
12.4.3 Yisheng Rabies Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Yisheng Rabies Vaccine Products Offered
12.4.5 Yisheng Recent Development
12.5 Prcmise
12.5.1 Prcmise Corporation Information
12.5.2 Prcmise Business Overview
12.5.3 Prcmise Rabies Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Prcmise Rabies Vaccine Products Offered
12.5.5 Prcmise Recent Development
12.6 VACN
12.6.1 VACN Corporation Information
12.6.2 VACN Business Overview
12.6.3 VACN Rabies Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.6.4 VACN Rabies Vaccine Products Offered
12.6.5 VACN Recent Development
12.7 Changsheng
12.7.1 Changsheng Corporation Information
12.7.2 Changsheng Business Overview
12.7.3 Changsheng Rabies Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Changsheng Rabies Vaccine Products Offered
12.7.5 Changsheng Recent Development
12.8 BCHT
12.8.1 BCHT Corporation Information
12.8.2 BCHT Business Overview
12.8.3 BCHT Rabies Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.8.4 BCHT Rabies Vaccine Products Offered
12.8.5 BCHT Recent Development
12.9 Hissen
12.9.1 Hissen Corporation Information
12.9.2 Hissen Business Overview
12.9.3 Hissen Rabies Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Hissen Rabies Vaccine Products Offered
12.9.5 Hissen Recent Development
13 Rabies Vaccine Manufacturing Cost Analysis
13.1 Rabies Vaccine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Rabies Vaccine
13.4 Rabies Vaccine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Rabies Vaccine Distributors List
14.3 Rabies Vaccine Customers
15 Market Dynamics
15.1 Rabies Vaccine Market Trends
15.2 Rabies Vaccine Drivers
15.3 Rabies Vaccine Market Challenges
15.4 Rabies Vaccine Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Rabies Vaccine Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Rabies Vaccine Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Rabies Vaccine Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Rabies Vaccine Sales (K Units) by Region (2016-2021)
Table 5. Global Rabies Vaccine Sales Market Share by Region (2016-2021)
Table 6. Global Rabies Vaccine Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Rabies Vaccine Revenue Share by Region (2016-2021)
Table 8. Global Rabies Vaccine Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Rabies Vaccine Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Rabies Vaccine Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Rabies Vaccine Revenue Share Forecast by Region (2022-2027)
Table 12. Global Rabies Vaccine Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Rabies Vaccine Sales Share by Company (2016-2021)
Table 14. Global Rabies Vaccine Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Rabies Vaccine Revenue Share by Company (2016-2021)
Table 16. Global Rabies Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rabies Vaccine as of 2020)
Table 17. Global Rabies Vaccine Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Rabies Vaccine Manufacturing Sites and Area Served
Table 19. Manufacturers Rabies Vaccine Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Rabies Vaccine Sales (K Units) by Type (2016-2021)
Table 22. Global Rabies Vaccine Sales Share by Type (2016-2021)
Table 23. Global Rabies Vaccine Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Rabies Vaccine Price (USD/Unit) by Type (2016-2021)
Table 25. Global Rabies Vaccine Sales Share by Type (2022-2027)
Table 26. Global Rabies Vaccine Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Rabies Vaccine Revenue Share by Type (2022-2027)
Table 28. Global Rabies Vaccine Price (USD/Unit) by Type (2022-2027)
Table 29. Global Rabies Vaccine Sales (K Units) by Application (2016-2021)
Table 30. Global Rabies Vaccine Sales Share by Application (2016-2021)
Table 31. Global Rabies Vaccine Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Rabies Vaccine Price (USD/Unit) by Application (2016-2021)
Table 33. Global Rabies Vaccine Sales (K Units) by Application (2022-2027)
Table 34. Global Rabies Vaccine Sales Share by Application (2022-2027)
Table 35. Global Rabies Vaccine Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Rabies Vaccine Revenue Share by Application (2022-2027)
Table 37. Global Rabies Vaccine Price (USD/Unit) by Application (2022-2027)
Table 38. North America Rabies Vaccine Sales (K Units) by Company (2016-2021)
Table 39. North America Rabies Vaccine Sales Market Share by Company (2016-2021)
Table 40. North America Rabies Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Rabies Vaccine Revenue Market Share by Company (2016-2021)
Table 42. North America Rabies Vaccine Sales by Type (2016-2021) & (K Units)
Table 43. North America Rabies Vaccine Sales Market Share by Type (2016-2021)
Table 44. North America Rabies Vaccine Sales by Type (2022-2027) & (K Units)
Table 45. North America Rabies Vaccine Sales Market Share by Type (2022-2027)
Table 46. North America Rabies Vaccine Sales by Application (2016-2021) & (K Units)
Table 47. North America Rabies Vaccine Sales Market Share by Application (2016-2021)
Table 48. North America Rabies Vaccine Sales by Application (2022-2027) & (K Units)
Table 49. North America Rabies Vaccine Sales Market Share by Application (2022-2027)
Table 50. Europe Rabies Vaccine Sales (K Units) by Company (2016-2021)
Table 51. Europe Rabies Vaccine Sales Market Share by Company (2016-2021)
Table 52. Europe Rabies Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Rabies Vaccine Revenue Market Share by Company (2016-2021)
Table 54. Europe Rabies Vaccine Sales by Type (2016-2021) & (K Units)
Table 55. Europe Rabies Vaccine Sales Market Share by Type (2016-2021)
Table 56. Europe Rabies Vaccine Sales by Type (2022-2027) & (K Units)
Table 57. Europe Rabies Vaccine Sales Market Share by Type (2022-2027)
Table 58. Europe Rabies Vaccine Sales by Application (2016-2021) & (K Units)
Table 59. Europe Rabies Vaccine Sales Market Share by Application (2016-2021)
Table 60. Europe Rabies Vaccine Sales by Application (2022-2027) & (K Units)
Table 61. Europe Rabies Vaccine Sales Market Share by Application (2022-2027)
Table 62. China Rabies Vaccine Sales (K Units) by Company (2016-2021)
Table 63. China Rabies Vaccine Sales Market Share by Company (2016-2021)
Table 64. China Rabies Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Rabies Vaccine Revenue Market Share by Company (2016-2021)
Table 66. China Rabies Vaccine Sales by Type (2016-2021) & (K Units)
Table 67. China Rabies Vaccine Sales Market Share by Type (2016-2021)
Table 68. China Rabies Vaccine Sales by Type (2022-2027) & (K Units)
Table 69. China Rabies Vaccine Sales Market Share by Type (2022-2027)
Table 70. China Rabies Vaccine Sales by Application (2016-2021) & (K Units)
Table 71. China Rabies Vaccine Sales Market Share by Application (2016-2021)
Table 72. China Rabies Vaccine Sales by Application (2022-2027) & (K Units)
Table 73. China Rabies Vaccine Sales Market Share by Application (2022-2027)
Table 74. Japan Rabies Vaccine Sales (K Units) by Company (2016-2021)
Table 75. Japan Rabies Vaccine Sales Market Share by Company (2016-2021)
Table 76. Japan Rabies Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Rabies Vaccine Revenue Market Share by Company (2016-2021)
Table 78. Japan Rabies Vaccine Sales by Type (2016-2021) & (K Units)
Table 79. Japan Rabies Vaccine Sales Market Share by Type (2016-2021)
Table 80. Japan Rabies Vaccine Sales by Type (2022-2027) & (K Units)
Table 81. Japan Rabies Vaccine Sales Market Share by Type (2022-2027)
Table 82. Japan Rabies Vaccine Sales by Application (2016-2021) & (K Units)
Table 83. Japan Rabies Vaccine Sales Market Share by Application (2016-2021)
Table 84. Japan Rabies Vaccine Sales by Application (2022-2027) & (K Units)
Table 85. Japan Rabies Vaccine Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Rabies Vaccine Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Rabies Vaccine Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Rabies Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Rabies Vaccine Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Rabies Vaccine Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Rabies Vaccine Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Rabies Vaccine Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Rabies Vaccine Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Rabies Vaccine Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Rabies Vaccine Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Rabies Vaccine Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Rabies Vaccine Sales Market Share by Application (2022-2027)
Table 98. India Rabies Vaccine Sales (K Units) by Company (2016-2021)
Table 99. India Rabies Vaccine Sales Market Share by Company (2016-2021)
Table 100. India Rabies Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Rabies Vaccine Revenue Market Share by Company (2016-2021)
Table 102. India Rabies Vaccine Sales by Type (2016-2021) & (K Units)
Table 103. India Rabies Vaccine Sales Market Share by Type (2016-2021)
Table 104. India Rabies Vaccine Sales by Type (2022-2027) & (K Units)
Table 105. India Rabies Vaccine Sales Market Share by Type (2022-2027)
Table 106. India Rabies Vaccine Sales by Application (2016-2021) & (K Units)
Table 107. India Rabies Vaccine Sales Market Share by Application (2016-2021)
Table 108. India Rabies Vaccine Sales by Application (2022-2027) & (K Units)
Table 109. India Rabies Vaccine Sales Market Share by Application (2022-2027)
Table 110. GSK (Novartis) Corporation Information
Table 111. GSK (Novartis) Description and Business Overview
Table 112. GSK (Novartis) Rabies Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. GSK (Novartis) Rabies Vaccine Product
Table 114. GSK (Novartis) Recent Development
Table 115. Sanofi-Pasteur Corporation Information
Table 116. Sanofi-Pasteur Description and Business Overview
Table 117. Sanofi-Pasteur Rabies Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Sanofi-Pasteur Rabies Vaccine Product
Table 119. Sanofi-Pasteur Recent Development
Table 120. Chengda Corporation Information
Table 121. Chengda Description and Business Overview
Table 122. Chengda Rabies Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Chengda Rabies Vaccine Product
Table 124. Chengda Recent Development
Table 125. Yisheng Corporation Information
Table 126. Yisheng Description and Business Overview
Table 127. Yisheng Rabies Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Yisheng Rabies Vaccine Product
Table 129. Yisheng Recent Development
Table 130. Prcmise Corporation Information
Table 131. Prcmise Description and Business Overview
Table 132. Prcmise Rabies Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Prcmise Rabies Vaccine Product
Table 134. Prcmise Recent Development
Table 135. VACN Corporation Information
Table 136. VACN Description and Business Overview
Table 137. VACN Rabies Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. VACN Rabies Vaccine Product
Table 139. VACN Recent Development
Table 140. Changsheng Corporation Information
Table 141. Changsheng Description and Business Overview
Table 142. Changsheng Rabies Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Changsheng Rabies Vaccine Product
Table 144. Changsheng Recent Development
Table 145. BCHT Corporation Information
Table 146. BCHT Rabies Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. BCHT Description and Business Overview
Table 148. BCHT Rabies Vaccine Product
Table 149. BCHT Recent Development
Table 150. Hissen Corporation Information
Table 151. Hissen Rabies Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. Hissen Description and Business Overview
Table 153. Hissen Rabies Vaccine Product
Table 154. Hissen Recent Development
Table 155. Production Base and Market Concentration Rate of Raw Material
Table 156. Key Suppliers of Raw Materials
Table 157. Rabies Vaccine Distributors List
Table 158. Rabies Vaccine Customers List
Table 159. Rabies Vaccine Market Trends
Table 160. Rabies Vaccine Market Drivers
Table 161. Rabies Vaccine Market Challenges
Table 162. Rabies Vaccine Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Rabies Vaccine Product Picture
Figure 2. Global Rabies Vaccine Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Rabies Vaccine Sales Market Share by Application in 2021 & 2027
Figure 6. Pre-exposure Prophylaxis Examples
Figure 7. Post-exposure Prophylaxis Examples
Figure 8. Global Rabies Vaccine Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Rabies Vaccine Sales Growth Rate (2016-2027) & (US$ Million)
Figure 10. Global Rabies Vaccine Sales (K Units) Growth Rate (2016-2027)
Figure 11. Global Rabies Vaccine Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 12. Global Rabies Vaccine Revenue Market Share by Region: 2016 VS 2021
Figure 13. Global Rabies Vaccine Revenue Market Share by Region: 2021 VS 2027
Figure 14. North America Rabies Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 15. North America Rabies Vaccine Sales (K Units) Growth Rate (2016-2027)
Figure 16. Europe Rabies Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. Europe Rabies Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 18. China Rabies Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. China Rabies Vaccine Sales (Million USD) and Growth Rate (2016-2027)
Figure 20. Japan Rabies Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Japan Rabies Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 22. Southeast Asia Rabies Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Rabies Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 24. India Rabies Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. India Rabies Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Global 5 Largest Rabies Vaccine Players Market Share by Revenue in Rabies Vaccine: 2016 & 2020
Figure 27. Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 28. Global Rabies Vaccine Revenue Share by Type (2016-2021)
Figure 29. Global Rabies Vaccine Revenue Growth Rate by Type in 2016 & 2020
Figure 30. Global Rabies Vaccine Revenue Share by Application (2016-2021)
Figure 31. Global Rabies Vaccine Revenue Growth Rate by Application in 2016 & 2020
Figure 32. North America Rabies Vaccine Sales Market Share by Type in 2020
Figure 33. North America Rabies Vaccine Sales Market Share by Application in 2020
Figure 34. Europe Rabies Vaccine Sales Market Share by Type in 2020
Figure 35. Europe Rabies Vaccine Sales Market Share by Application in 2020
Figure 36. China Rabies Vaccine Sales Market Share by Type in 2020
Figure 37. China Rabies Vaccine Sales Market Share by Application in 2020
Figure 38. Japan Rabies Vaccine Sales Market Share by Type in 2020
Figure 39. Japan Rabies Vaccine Sales Market Share by Application in 2020
Figure 40. Southeast Asia Rabies Vaccine Sales Market Share by Type in 2020
Figure 41. Southeast Asia Rabies Vaccine Sales Market Share by Application in 2020
Figure 42. India Rabies Vaccine Sales Market Share by Type in 2020
Figure 43. India Rabies Vaccine Sales Market Share by Application in 2020
Figure 44. Key Raw Materials Price Trend
Figure 45. Manufacturing Cost Structure of Rabies Vaccine
Figure 46. Manufacturing Process Analysis of Rabies Vaccine
Figure 47. Rabies Vaccine Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
ヒト狂犬病ワクチンのグローバル市場調査 2019年 The global Human Rabies Vaccine market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Human Rabies Vaccine volume and value at global level, regional level and company level. From a global perspective, th…- 世界の狂犬病治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Rabies Treatment Market The global Rabies Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a b…
- 世界のヒト狂犬病治療市場規模・現状・予測（2021年-2027年） Rabies is a fatal neurological disease, usually spread to humans through the bite of a rabid animal, and it is a persistent global problem. Market Analysis and Insights: Global Human Rabies Treatment Market The global Human Rabies Treatment market size is projected to reach US$ XX million by 2027, f…
- 世界の狂犬病モノクローナル抗体市場規模・現状・予測（2021年-2027年） Anti-rabies virus monoclonal antibody is a passive immune preparation, which has the same or better neutralizing effect as rabies immunoglobulin. The development of anti-rabies virus monoclonal antibodies to replace traditional human immunoglobulin and immune antiserum products is an important direc…
- 狂犬病治療のグローバル市場調査 2019年 The global Rabies Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Rabies Treatment volume and value at global level, regional level and company level. From a global perspective, this repor…